| Lara Alicia Mcknight, OD | |
|
4530 S Carson St Ste 12, Carson City, NV 89701-6914 | |
| (775) 267-2000 | |
| Not Available |
| Full Name | Lara Alicia Mcknight |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 22 Years |
| Location | 4530 S Carson St Ste 12, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649281403 | NPI | - | NPPES |
| P00218425 | Other | NV | RR # |
| 100501811 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD481 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eyes On Carson | 1658265012 | 3 |
News Archive
In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Helen Matzger, a program officer in new vaccine delivery at the foundation, writes about outbreaks of cholera in Haiti, Sierra Leone, Guinea, and other areas, and says creating stockpiles of a recently WHO-approved cholera vaccine could help save lives in the future.
CPL Biologicals (CPLB), a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc., today announced that it has completed construction of its vaccine facility in Dholka, India and will commence equipment and installation validation this month so that the facility conforms to global standards for production of vaccines for human use.
New research just out in the journal Science Translational Medicine opens the door for the development of treatments capable of stopping Alzheimer's disease (AD) before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear making this preclinical period (pre-symptoms) the ideal time to intervene.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
Linda Buck, Ph.D., a member of Fred Hutchinson Cancer Research Center's Basic Sciences Division, has been named winner of the 2004 Nobel Prize in physiology or medicine.
› Verified 1 days ago
| Provider Name | Lara Mcknight, Od & Assoc Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245576768 PECOS PAC ID: 1658265012 Enrollment ID: O20040209000614 |
News Archive
In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Helen Matzger, a program officer in new vaccine delivery at the foundation, writes about outbreaks of cholera in Haiti, Sierra Leone, Guinea, and other areas, and says creating stockpiles of a recently WHO-approved cholera vaccine could help save lives in the future.
CPL Biologicals (CPLB), a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc., today announced that it has completed construction of its vaccine facility in Dholka, India and will commence equipment and installation validation this month so that the facility conforms to global standards for production of vaccines for human use.
New research just out in the journal Science Translational Medicine opens the door for the development of treatments capable of stopping Alzheimer's disease (AD) before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear making this preclinical period (pre-symptoms) the ideal time to intervene.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
Linda Buck, Ph.D., a member of Fred Hutchinson Cancer Research Center's Basic Sciences Division, has been named winner of the 2004 Nobel Prize in physiology or medicine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lara Alicia Mcknight, OD Po Box 3186, Carson City, NV 89702-3186 Ph: (775) 267-2000 | Lara Alicia Mcknight, OD 4530 S Carson St Ste 12, Carson City, NV 89701-6914 Ph: (775) 267-2000 |
News Archive
In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Helen Matzger, a program officer in new vaccine delivery at the foundation, writes about outbreaks of cholera in Haiti, Sierra Leone, Guinea, and other areas, and says creating stockpiles of a recently WHO-approved cholera vaccine could help save lives in the future.
CPL Biologicals (CPLB), a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc., today announced that it has completed construction of its vaccine facility in Dholka, India and will commence equipment and installation validation this month so that the facility conforms to global standards for production of vaccines for human use.
New research just out in the journal Science Translational Medicine opens the door for the development of treatments capable of stopping Alzheimer's disease (AD) before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear making this preclinical period (pre-symptoms) the ideal time to intervene.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
Linda Buck, Ph.D., a member of Fred Hutchinson Cancer Research Center's Basic Sciences Division, has been named winner of the 2004 Nobel Prize in physiology or medicine.
› Verified 1 days ago
Dr. Katrina Copoulos, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 410 Fleischmann Way, Carson City, NV 89703 Phone: 775-882-3977 Fax: 775-882-3285 | |
Mrs. Jennifer Lynne Peterson Highley, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 844 W Nye Ln Ste 104, Carson City, NV 89703 Phone: 775-882-3937 | |
Gary W Abel, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 680 W Nye Ln Ste 102, Carson City, NV 89703 Phone: 775-884-4488 | |
Pritchett Eye Care Associates- Carson Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1987 N Carson St Ste 5, Carson City, NV 89701 Phone: 775-883-2015 Fax: 775-883-5805 | |
Dr. Benjamin Clark Seljestad, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 700 Old Clear Creek Rd, Carson City, NV 89705 Phone: 775-884-2020 | |
Dr. Raymond James Ruckman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 111 W Tenth St, Carson City, NV 89703 Phone: 775-883-4664 Fax: 775-883-4750 | |
Vision Consultants Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3050 N Ormsby Blvd, Carson City, NV 89703 Phone: 775-841-4646 |